echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAHA: Relationship between the N end of the brain and atrial sodium peptide preaphed and the dynamic brain auto-regulation.

    JAHA: Relationship between the N end of the brain and atrial sodium peptide preaphed and the dynamic brain auto-regulation.

    • Last Update: 2020-10-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Elevated sodium peptide (NP) is associated with adverse cerebrovascular diseases, including stroke, cerebrovascular disease and dementia.
    , however, the mechanisms for these associations are not yet clear.
    a recent study published in JAHA, an authoritative journal in the field of cardiovascular disease, in which researchers evaluated the relationship between the N-end of the cerebrosine peptide prebiotor (NT-proBNP) and the N-end of the atrial sodium peptide presage (NT-proANP) and cerebrovascular function.
    researchers included 154 participants in the Young Coronary Arterial Risk Development (CARDIA) queue (with an average age of 56±4 years), who measured NT-proBNP and NT-proANP levels using electrochemical luminescent immunoassays and enzyme-linked immunoassays from blood samples taken during the 25th year of assessment, respectively.
    Dynamic Brain Auto-Regulation (dCA) was determined in the 30th year of the assessment by a cranial Doppler ultrasound, and the researchers used a transfer function analysis (phase and gain) of spontaneous blood pressure and flow rate oscillations, where lower phases and higher gain reflected lower brain auto-regulation efficiency.
    researchers used a multivariable linear regression model that adjusted demographics, vascular risk factors, and the history of kidney and heart disease.
    25th year higher NT-proBNP levels are associated with lower phases (β-5.30), lower phase amplitudes (-10.05 to -0.54) and higher gain (β (95%CI) and 0.06 (0.004-0.12 cm/smHg).
    , higher NT-proANP levels are associated with lower phases (β--9.08) and lower phase amplitudes (-16.46 to -1.70).
    , it can be seen that higher NT-proBNP and NT-proANP levels are associated with lower dCA efficiency.
    these results suggest a link between circulating NP and automatic brain regulation, possibly a mechanism for linking NP to poor cerebrovascular prognosmation.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.